Hemogenyx Pharmaceuticals Plc (HEMO.L)
GBp 320.0
(-8.57%)
GBp 320.0
(-8.57%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.01 GBP | -34.09% |
| 2022 | -0.00 GBP | 54.64% |
| 2021 | -0.01 GBP | -90.2% |
| 2020 | -0.01 GBP | -27.5% |
| 2019 | -0.00 GBP | 2.44% |
| 2018 | -0.00 GBP | 54.95% |
| 2017 | -0.01 GBP | -13.75% |
| 2016 | -0.01 GBP | 44.06% |
| 2015 | -0.01 GBP | -14200.0% |
| 2014 | -0.00 GBP | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | - GBP | 100.0% |
| 2024 Q1 | -0.00 GBP | -10.0% |
| 2023 Q4 | -0.00 GBP | 0.0% |
| 2023 FY | - GBP | -34.09% |
| 2023 Q2 | -0.00 GBP | 0.0% |
| 2023 Q3 | - GBP | 100.0% |
| 2023 Q1 | - GBP | 100.0% |
| 2022 Q2 | -0.00 GBP | 0.0% |
| 2022 Q1 | - GBP | 100.0% |
| 2022 Q4 | -0.00 GBP | 0.0% |
| 2022 FY | - GBP | 54.64% |
| 2022 Q3 | - GBP | 100.0% |
| 2021 Q3 | -0.00 GBP | 89.39% |
| 2021 Q2 | -0.01 GBP | -100.0% |
| 2021 Q1 | -0.00 GBP | -13.79% |
| 2021 Q4 | -0.00 GBP | -114.29% |
| 2021 FY | - GBP | -90.2% |
| 2020 Q1 | -0.00 GBP | 52.38% |
| 2020 FY | - GBP | -27.5% |
| 2020 Q3 | -0.00 GBP | 33.33% |
| 2020 Q4 | -0.00 GBP | -107.14% |
| 2020 Q2 | -0.00 GBP | -110.0% |
| 2019 Q1 | -0.00 GBP | 16.67% |
| 2019 Q4 | -0.00 GBP | -110.0% |
| 2019 FY | - GBP | 2.44% |
| 2019 Q2 | -0.00 GBP | -100.0% |
| 2019 Q3 | -0.00 GBP | 50.0% |
| 2018 Q3 | -0.00 GBP | -33.33% |
| 2018 Q2 | -0.00 GBP | 0.0% |
| 2018 Q1 | -0.00 GBP | 76.32% |
| 2018 FY | - GBP | 54.95% |
| 2018 Q4 | -0.00 GBP | 0.0% |
| 2017 Q4 | -0.00 GBP | 0.0% |
| 2017 Q2 | -0.00 GBP | 0.0% |
| 2017 Q3 | -0.00 GBP | -1166.67% |
| 2017 Q1 | -0.00 GBP | 0.0% |
| 2017 FY | - GBP | -13.75% |
| 2016 Q4 | - GBP | 0.0% |
| 2016 Q2 | - GBP | 0.0% |
| 2016 FY | - GBP | 44.06% |
| 2015 FY | - GBP | -14200.0% |
| 2014 FY | - GBP | 0.0% |
| Name | Eps | Eps Difference |
|---|